Pulmonary deposition and disappearance of aerosolised secretory leucocyte protease inhibitor

Thorax

Volumn 50, Issue 6, 1995, Pages 645-650

  Stolk, J ^a   Camps, J ^a   Feitsma, H I J ^a   Hermans, J ^a   Dijkman, J H ^a   Pauwels, E K J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antileucoprotease; Antiprotease; Cystic fibrosis; Emphysema; Protease

Indexed keywords

ELASTASE; PROTEINASE INHIBITOR; TECHNETIUM 99M;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG EFFECT; DRUG EFFICACY; HUMAN; HUMAN EXPERIMENT; LUNG EMPHYSEMA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SCINTIGRAPHY; SCINTISCANNING;

ADULT; AEROSOLS; ALPHA 1-ANTITRYPSIN DEFICIENCY; ANIMALS; CRICETINAE; CYSTIC FIBROSIS; HALF-LIFE; HUMANS; LUNG; MALE; MESOCRICETUS; PHENOTYPE; PROTEINASE INHIBITORY PROTEINS, SECRETORY; PROTEINS; PULMONARY EMPHYSEMA; RECOMBINANT PROTEINS; SECRETORY LEUKOCYTE PEPTIDASE INHIBITOR; SERINE PROTEINASE INHIBITORS; SODIUM PERTECHNETATE TC 99M;

EID: 0029077691     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.50.6.645     Document Type: Article

References (0)